The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 6 results:
Author Title [ Type(Desc)] Year
Filters: Author is Makri, Evangelia S  [Clear All Filters]
Journal Article
Tontikidou, C., Makri E. S., Evripidou K., Goulis D. G., Goulas A., & Polyzos S. A. (2022).  Circulating adiponectin in patients with nonalcoholic fatty liver disease-related liver fibrosis: A systematic review and a meta-analysis.. J Gastroenterol Hepatol.
Makri, E., Orfanidou M., Makri E. S., Goulas A., Terpos E., & Polyzos S. A. (2024).  Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.. J Clin Exp Hepatol. 14(3), 101353.
Makri, E. S., Evripidou K., & Polyzos S. A. (2024).  Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.. J Gastroenterol Hepatol.
Makri, E. S., Makri E., & Polyzos S. A. (2022).  Combination Therapies for Nonalcoholic Fatty Liver Disease.. J Pers Med. 12(7), 
Makri, E. S., Xanthopoulos K., Parasidis P. Mavrommati, Makri E., Pettas S., Tsingotjidou A., et al. (2024).  Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease.. Endocrine.
Makri, E. S., Goulas A., & Polyzos S. A. (2021).  Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease.. Eur J Pharmacol. 907, 174272.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.